Company news
Wuhan Healthgen Biotechnology Corp Class A (SSE:688765) news
Wuhan Healthgen Biotechnology Corp Class A news releases on 6ix. Latest, Sep 30, 2026: "WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Pledge and Release…
Press releases & updates
"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Pledge and Release of Pledge of Certain Shares Held by Shareholder Holding More Than 5% of the Shares
September 29, 2026
"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."2026 Semi-annual Continuous Supervision and Guidance Follow-up Report of GUOTAI HAITONG SECURITIES CO., LTD. on WUHAN HEALTHGEN BIOTECHNOLOGY CORP.
September 10, 2026
"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
September 8, 2026
"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Semi-annual Report for 2026
August 26, 2026
"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Listing and Trading of Certain Restricted Shares from Offline Placement in the Initial Public Offering
July 20, 2026
"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction and 2025 Annual Performance Briefing
July 1, 2026
Announcement on Wholly-owned Subsidiary Opening Special Account for Raised Funds and Signing Supervision Agreement
June 24, 2026
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
June 1, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 19, 2026
Announcement on Pledge of Partial Shares by Shareholders with Over 5% of Shares
May 18, 2026
Semi-annual Tracking Report on Continuous Supervision of WUHAN HEALTHGEN BIOTECHNOLOGY CORP. in 2025
May 12, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 5, 2026
On-site Inspection Report on Continuous Supervision of WUHAN HEALTHGEN BIOTECHNOLOGY CORP. by GUOTAI HAITONG SECURITIES CO., LTD. in 2025
April 28, 2026
Notice on Convening the 2025 Annual General Meeting
April 27, 2026
Announcement on Circulation of Restricted Stocks in Offline Placement of Initial Public Offering
April 20, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 26, 2026
Earnings Preannouncement for 2025
January 28, 2026
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
December 12, 2025
Announcement on Replacing with Raised Funds Self-raised Funds Invested in Advance in Investment Projects Financed by Raised Funds and Used to Pay Issuance Fee
November 23, 2025